OCT 1 8 2006
K 062097
—
510(k) SUMMARY
1. Submitter Name and Address
SurgRx, Inc.
101 Saginaw Drive
Redwood City, CA 94063
Contact: Linda Oleson
Phone: (650) 482-2400 ext 107
Date: 10/6/06
2. Device Name
Trade name: EnSeal Vessel Sealing & Hemostasis System
Common name: Electrosurgical open and laparoscopic instruments and accessories
Classification name: Electrosurgical Cutting and Coagulation Device and Accessories
(per 21 CFR section 878.4400) and Gynecologic Electrocautery and Accessories (per 21
CFR 884.4120).
3. Predicate Device
EnSeai™ Vessel Sealing and Hemostasis System # K061526
4. Device Description
EnSeal™ Vessel Sealing and Hemostasis System. The functionality of the System is the
same as the predicate device.
5. Intended Use
The SurgRx EnSeal devices are intended for use during open or laparoscopic general
and gynecologic surgery to cut and seal vessels, cut, grasp and dissect tissue and/or
seal vessels during surgery. The SurgRx EnSeal Vessel Sealing & Hemostasis System
has not been shown to be effective for tubal sterilization or tubal coagulation for
Sterilization procedures. Do not use this system for these procedures.
6. Technological Characteristics ©
The EnSeal electrosurgical instruments are the same as the predicate devices utilizing
RF powered bipolar distal ends.
7. Performance Data
Preclinical laboratory (bench) and performance tests were executed to ensure the
devices function as intended and meet design specifications.
8. Conclusions
The EnSeal System is equivalent to the predicate device based on results of design
validation. We believe that the EnSeal devices are safe and effective and substantially
equivalent to the predicate device.

i C DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
fin, "
wok Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
OCT 18 2006
SurgRx, Inc.
% Ms. Linda S.M. Oleson
Director of Clinical & Regulatory Affairs
101 Saginaw Drive
Redwood City, California 94063
Re: K063097
Trade/Device Name: SurgRx EnSeal Vessel Sealing & Hemostasis System
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI, HGI
Dated: October 6, 2006
Received: October 10, 2006
Dear Ms. Oleson:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). Youmay,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class If (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the
quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product
radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Ms. Linda S.M. Oleson
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain other
general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www. fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

be Vy a)

Mark N. Melkerson

Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
. Radiological Health

Enclosure :

Indications for Use Statement
Applicant: SurgRx, Inc. ,
510(k) number (if known): b Ob309 7
Device Name: SurgRx EnSeal Vessel Sealing & Hemostasis System
Indications for Use:
. The SurgRx EnSeal system includes bipolar electrosurgical instruments and a
radiofrequency generator. It is intended for use during open or laparoscopic, general and
, gynecologic surgery to cut and seal vessels, cut, grasp and dissect tissue during surgery.
Indications for use include open and laparoscopic general and gynecological surgical
procedures (including urologic, thoracic, plastic and reconstructive, bowel resections,
hysterectomies, cholecystectomies, gall bladder procedures, Nissen fundoplication,
adhesiolysis, oophorectomies, etc.), or any procedure where vessel ligation (cutting and
sealing), tissue grasping and dissection is performed. The devices can be used on
vessels up to (and including) 7 mm and bundles as large as will fit in the jaws of the
instruments.
The SurgRx EnSeal Vessel Sealing & Hemostasis System has not been shown to be
effective for tubal sterilization or tubal coagulation for sterilization procedures. Do not use
this system for these procedures.
Prescription Use AND/OR Over-The-Counter Use
(Per 21 CFR 801 Subbart D) (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE ~ CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division hy Division of General, Restorative
. , Page 1 of 1
and Neurological Devices
A-|
° YS 047)
510(k) Number Loe bO)

